CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

HSBC Adjusts Price Target on Biogen to $165 From $157, Keeps Reduce Rating

Neutral
AI Analysis

Summary

HSBC raised its price target on Biogen to $165 from $157 while maintaining a Reduce rating.

Importance:1/10
Sentiment:
-0.20
price_targetanalyst_ratingequity_research
Related Companies

Read the original article

Published by yahoo_finance on August 10, 2026 12:31 PM

Read Original